Immunoscintigraphy of Infections Using 123I and 99mTc-Labeled Monoclonal Antibodies. Advanced Experiences in 230 Patients
- 1 February 1992
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 43 (2) , 85-90
- https://doi.org/10.1177/000331979204300201
Abstract
Advanced experiences show an extremely high diagnostic potential in im munoscintigraphy of infections using monoclonal antigranulocytes antibodies (Mab). There was no hampering of the biological properties of the granulocytes after in vivo labeling with123I or99mTc-tagged Mabs. There were mostly identi cal findings and an equal functional behavior of the granulocytes observed with the use of different agents. Diagnosis of infections was made mostly within four to six hours p.i.99mTc labeling is more advantageous than123 I because of better image quality, constant availability, and lower costs.123I Mab 47 seems to be recommended in some cases of chronic osteomyelitis and spondylitis. No rele vant antigenicity was observed in follow-up studies of testing HAMA serum levels. Only a few short-time reactions were seen after repeated administration of99mTc Mab. There were no side effects and no allergic or adverse reactions. Despite these methodical advantages of the immunoscintigraphic detection of infectious and inflammatory lesions, this method should be further restricted to severe cases or patients in whom other methods would not be practicable or have failed. HAMA controls are continued in all our patients undergoing im munoscintigraphy.Keywords
This publication has 4 references indexed in Scilit:
- Immunoscintigraphic localization of inflammatory lesions: Clinical experienceEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988
- Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti-granulocytes antibodiesNuclear Medicine Communications, 1986
- Immunohistochemical localization and molecular characteristics of three monoclonal antibody‐defined epitopes detectable on carcinoembryonic antigen (CEA)International Journal of Cancer, 1985
- Monoclonal antibodies identify a cea crossreacting antigen of 95 kD (NCA‐95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kDInternational Journal of Cancer, 1984